Remote Monitoring of Adverse Events

Slides:



Advertisements
Similar presentations
Susan Burner Bankowski, M.S., J.D. Chair, OHSU IRB
Advertisements

Safety Reporting IN Clinical Trials
ADVERSE EVENT REPORTING
Pharmacovigilance Dr. Muiris Dowling,
Adverse Event Reporting. Reporting Adverse Events Adverse Events (AEs) are “... any untoward medical occurrence in a subject that was not previously identified.
Reporting Unanticipated Problems Involving Risk to Subjects or Others and Adverse Events WFUHS Policy/Procedure Effective Date 6/1/07 Wendy Murray Monitoring.
SAE Reconciliation How to handle ‘a waterfall’ of SAEs?
Update: 21 CFR PART 312 FDA Safety Reporting Requirements for INDs
Capturing and Reporting Adverse Events in Clinical Research
Fulfilling the Promise of Medicine Together New FDA Safety Reporting Requirements 2010 John McLane, Ph.D. COO & Vice President Clinical and Regulatory.
Human Research Protection Program Training: Post-Approval Event Reporting March 26, 2008 Lisa Voss, MPH, CIP Assistant Director, QIU Human Research Protection.
Basic Pharmacovigilance Training
FDA MedWatch and Patient Safety. Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006  The Act defines a ‘serious adverse event’
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
SERIOUS ADVERSE EVENTS REPORTING Elizabeth Dayag IRB Administrator Naval Medical Center Portsmouth.
Adverse Events and Unanticipated Problems Presented by: Karen Jeans, PhD, CCRN, CIP COACH Program Analyst.
1 Nuts and Bolts of Safety Reporting The Role of the CRO Dr. Noa Lowenton Spier Pharma-Clinical S.A.G.
Adverse Event Reporting.
H. Lundbeck A/S21-Sep-151 Pharmacovigilance during clinical development SAE reporting, ASUR and PSUR IFF Seminar, 21. February 2007.
Research Studies GOTCHA’S By Sally Duffy. Failure to follow protocol, investigator agreements and regulations Did not use device/drug in manner specified.
Alice Chen, MD, FACP Investigational Drug Branch, CTEP, DCTD National Cancer Institute CTCAE Version 4.
AE/SAE/EAE Identification and Reporting AE/SAE/EAE Identification and Reporting.
EAE Training EAE Reporting and Assessment Overview DAIDS Regional Training Event, Regulatory Compliance Center Kampala, Uganda, September 2009 DAIDS Regional.
Serious Adverse Event Reporting Start-up Meeting March 25, 2010 Kingston, ON.
Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU) SAR/SUSAR Mette Krag Dept. of Intensive Care 4131 Copenhagen University Hospital Rigshospitalet,
Role of Site Investigator Ensure subject safety is protected & well-managed Full compliance with requirements of Good Clinical Practice (GCP) Conduct the.
Reporter Training for High School RIO TM
D3 ) Not Recovered d5) Fatal Was a post-mortem undertaken?YesNo Was the SAE ongoing at time of death from other cause? Yes No d d m m y y y y d1) Recovered.
1 SAE Centralized Report and Review Process April 2012.
CLINICAL TRIALS.
ASK MBSAQIP Agenda ASK MBSAQIP November 10, 2016 Time (CST)
REPORTING ADVERSE EVENTS AND COMPLETING THE REPORT FORM
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Dartmouth Human Research Protection Program (HRPP) Data Safety Monitoring and Reporting requirements Brown Bag Series: Noon / First Tuesday of the Month.

CCC Appointments/Scheduling
Reportable Events Emory IRB 9/11/2014.
Message Center Training
Assessing expectedness of an adverse event
TCP LIMS – Animal Use Protocol Management
Safety Reporting Nichol McBee, MPH, CCRP.
Expedited Adverse Event Reporting Requirements
Social Network Website for USEP
Remote Monitoring of Adverse Events
Copenhagen University Hospital Rigshospitalet, Denmark
3. Key definitions Multi-partner training package on active TB drug safety monitoring and management (aDSM) July 2016.
Pharmacovigilance in clinical trials
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Expedited Adverse Event Reporting Requirements
*Continue on SAE supplemental page CTT21 A if more space is required
Remote Monitoring of Protocol Deviations
Society for Clinical Trials 37th Annual Meeting 2016
Continuous Quality Improvement
Navigating Non-Compliance
SERIOUS ADVERSE EVENTS REPORTING
Society for Clinical Trials, 37th Annual Meeting
NHS Adult Inpatient Survey 2018
To Admit…or not to Admit…that is the question!
WHAT TO DO IF A PATIENT DEVELOPS AN UNEXPECTED PROBLEM?
How do I file an ASAP? Got to AMT home page
Reporter Training for High School RIOTM
Request Form You gain access to the Request Form from your intranet set-up by your IT dept. Or the internet via either our desktop launcher icon. Or a.
E-CRF Overview Oracle® Clinical Remote Data Capture Training (Version 4.6 HTML) e-CRF Completion John McDonach Manager CDM, PPD.
Ramy Abdelrahman, MD Division of Pediatric and Maternal Health (DPMH)
State of New Jersey Department of Health Patient Safety Reporting System Module 3 – Root Cause Analysis.
Model Enhanced Classification of Serious Adverse Events
Adverse Event Reporting _____________________________
Dr Tim England TICH-2 SAE adjudicator
Serious Adverse Event Reconciliation
Reporter Training for High School RIOTM
Presentation transcript:

Remote Monitoring of Adverse Events Dee Blumberg, PhD

Adverse Events An adverse event (AE) is any untoward medical occurrence associated with the use of a drug in humans, whether or not considered drug related (21 CFR 312.32). FDA 21 312.32 Code of Federal Regulations

Serious Adverse Event An adverse event or suspected adverse reaction is considered “serious” if, in the view of either the investigator or sponsor, it results in any of the following outcomes (21 CFR 312.32): death a life-threatening adverse event, inpatient hospitalization or prolongation of existing hospitalization a persistent or significant incapacity or substantial disruption of the ability to conduct normal life functions a congenital anomaly/birth defect important medical events Important medical events that based on medical judgment may jeopardize the patient and require medical intervention to prevent one of the outcomes in the definition…

AE/SAE Reporting Timelines All AEs and SAEs are entered in the EDC AEs- within 7 days of site becoming aware SAEs- within 24 hrs of site becoming aware The report generates an email notification to Safety Monitor, Data Manager, Protocol Specialist, Sponsor and Investigators (can be customized to include DSMB, pharma companies and any others) Timing of 7 days for AEs is a pretty standard time, 24 hours for SAEs is fixed

Automated Notification

Add that all rest of conversation is documented through edc, give eg of another email in my box or comm. With safety monitor…

AE/SAE Review AEs documented in 3 linked eCRFs: The Adverse Events form (AD1)- the main adverse events form captures information for AEs meeting protocol specified reporting criteria. The Serious Adverse Events Summary form (AD2)- captures safety data for those events associated with serious adverse event criteria. Serious Adverse Event Medical Reviewer form (AD3)- captures medical monitor determinations about each serious adverse event and requests made by the medical monitors for further information about the event. Don’t get into too much detail here…. At Emmes the medical monitor review is also documented in the system- that is different from most places… nothing else is unique

Adverse Events Form- AD1 The Adverse Events form - (AD1) is the main adverse events form and captures information for adverse events meeting protocol specified reporting criteria. SAE determination is made by the system

Serious Adverse Events Summary Form- AD2 SAE and supporting documents are available for the safety team to review (it asks for them to upload docs into the system) If a serious adverse event is reported on the Adverse Event form (AD1), the link "Serious Adverse Events Summary" in the toolbar of the form becomes available (see below). Click on the link to navigate to the form and enter in all available information into the appropriate fields. Additional Medical Monitor Information: Question 7 (Additional information requested by the Medical Monitor) is a read-only field that indicates what, if any, further information about the event has been requested by the Medical Monitor. Provide follow-up information in question 6 (follow-up) if the Medical Monitor requests it after initial SAE review. Once the requests in this field have been addressed in question 6, indicate this by checking the “Have all Medical Monitor requests been addressed” checkbox underneath question 7. As long as this field remains checked, no further requests have been made by the Medical Monitor.

AD2 Cont. Qu. 7 is a read only field that indicates what info is requested by the MM. Need to provide follow up info in Qu6 if MM requests it after initial SAE review. Once all requests in this field (7) have been addressed (in 6) check the box at the bottom- that all MM requests have been addressed. Documents can be attached to this form (associated with Qu 1 or 6)- no peronally identifying info (PHI) like name or initials…

Serious Adverse Events Medical Reviewer Form - AD3 Medical monitor reviews SAEs directly in the EDC This is where medical monitor review is documented…. Serious Adverse Event Medical Reviewer form - (AD3) captures medical monitor determinations about each serious adverse event and requests made by the medical monitors for further information about the event. The form is read only for everyone but the MM.

Monitoring AEs via Weekly Reports Clinical Coordinating Center receive weekly system- generated reports of AEs Reports are formatted as Excel documents Can be sorted as needed Highlighted as needed (e.g., certain severity) Clinical Coordinating Center (CCC) Staff (e.g., Safety Monitor) receive weekly system-generated reports of Aes

Conclusions Advantages: Real time attention to SAEs Medical Monitor reviews directly in the EDC and Communicates to research staff Medical Monitor locks reviewed SAEs Patterns trends from weekly reports… Weekly AE reports just like PD report– allow for monitoring the events that happens all week. Look for trends… training as needed… Screenshot of weekly report where causality is YES and circle/highlight that to show attnetion to it… So email notification and weekly reports- 2 ways of monitoring…

Questions? Comments?

Thank you!